http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-981242-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 1961-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1965-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-981242-A
titleOfInvention Vaccines containing rare earth salts
abstract The antigenicity of vaccines containing antigenic material of microbial origin is enhanced by mixing with the vaccine a salt containing a rare earth cation associated with an immunologically acceptable anion. A concentration between about 2 g. and about 0.008 g. of the rare earth cation is employed per 100 ml. of vaccine. Preferably, an aqueous solution of a water-soluble salt of the rare earth cation is added to the vaccine, but the vaccine may be added to a water-insoluble salt of the rare earth cation. Lanthanum and cerium salts may be used, particularly the acetate. Vaccines specified are Pulpy kidney, Braxy, Blackleg, Braxy-blackleg-pulpy kidney and a seven valent vaccine for diseases of the sheep. The invention also relates to the treatment of diseases in animals due to pathogenic microbes by the parenteral administration of the above vaccines.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0232717-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0232717-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7387900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785202-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5656298-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5112606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3522347-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6528051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42524-E
priorityDate 1961-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577485

Total number of triples: 30.